Arbutus Biopharma Corporation logo
Arbutus Biopharma Corporation ABUS
€ 3.26 0.0%

Quartalsbericht 2024-Q3
hinzugefügt 06.11.2024

report update icon

Arbutus Biopharma Corporation Kennzahlen 2011-2024 | ABUS

Kennzahlen Jährlich Arbutus Biopharma Corporation

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-6.1 -6.1 -5.4 -4.7 -1.0 -3.6 -3.3 -0.4 -2.3 -14.8 -14.1 2.2 -2.5

P/S

24.5 10.8 37.6 43.5 26.5 34.5 26.0 90.7 5.7 38.4 12.9 4.7 1.5

EPS

-0.4 -0.5 -0.8 -1 -2.9 -1.2 -1.6 -7.2 -1.4 -1.8 -0.9 2.2 -0.9

EV (Enterprise Value)

457 M 449 M 339 M 283 M 160 M 196 M 279 M 185 M 141 M 533 M 143 M 31 M 23.8 M

EBITDA per Share

-0.46 -0.42 -0.68 -0.696 -1.21 -1.23 -1.26 -1.87 -1.17 -1.45 -0.754 2.52 -0.828

EV/EBITDA

-3.4 -4.5 -1.8 -2.5 -3.5 -1.2 0.5 -15.5 -11.3 0.6 -1.6

PEG

0.41 0.35 0.33 -0.07 0.01 -0.16 -0.04 0.0 -0.1 0.17 0.1 0.01 -0.09

P/B

4.2 3.1 2.4 2.9 2.2 1.0 1.5 0.7 0.3 6.5 3.4 1.6 4.7

P/CF

-5.2 -11.9 -6.1 -5.8 -2.2 -3.0 -5.0 -2.2 -2.5 -42.6 -26.7 2.0 -3.2

ROE %

-68.71 -50.75 -45.00 -62.52 -211.32 -28.50 -46.26 -189.24 -11.16 -44.12 -23.76 73.18 -186.95

ROA %

-50.45 -35.54 -37.29 -46.50 -145.66 -25.04 -35.59 -139.23 -8.58 -32.86 -19.61 56.93 -71.02

ROCE %

-73.67 -47.83 -43.39 -44.90 -73.02 -32.39 -31.52 -37.80 -7.65 -33.65 -20.53 80.85 -150.45

Current Ratio

3.8 3.3 5.8 13.4 12.0 11.5 8.8 12.5 17.4 5.8 5.6 4.7 1.7

DSO

31.5 10.5 36.7 69.3 73.1 111.7 29.7 169.9 20.3 61.7 8.7 89.0 30.6

DIO

- - - - - - - - - - - - -

DPO

- - - 23.0 15.2 20.1 11.6 19.2 18.5 19.3 20.7 16.2 -

Betriebszyklus

31.5 10.5 36.7 69.3 73.1 111.7 29.7 169.9 20.3 61.7 8.7 89.0 30.6

Finanzkreislauf

31.5 10.5 36.7 46.2 57.9 91.6 18.1 150.7 1.8 42.4 -12.0 72.8 30.6

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Arbutus Biopharma Corporation

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.1 -0.11 -0.1 - -0.12 -0.1 -0.1 - -0.12 -0.1 -0.11 - -0.24 -0.23 -0.21 - -0.27 -0.25 -0.25 -0.46 -1.5 -0.46 -0.47 -0.38 -0.49 0.01 -0.36 -0.67 -0.21 -0.33 -0.34 -4.05 -0.37 -2.47 -0.31 -0.1 -0.57 -0.27 -0.4 -0.27 -0.39 -0.28 -0.91 -0.15 -0.41 -0.21 -0.18 - - - - - - - -

EBITDA per Share

- - -0.11 - - - -0.11 - -0.11 -0.09 -0.07 - -0.17 -0.19 -0.16 - -0.17 -0.17 -0.19 -0.2 -1.59 -0.35 -0.34 -0.3 -0.58 -0.39 -0.32 -1.09 -0.22 -0.35 -0.33 -4.69 -0.35 -3.7 -0.38 -0.22 -1.14 -0.26 -0.59 -0.48 -0.3 -0.42 -0.29 -0.13 -0.24 -0.2 -0.2 - - - - - - - -

ROE %

-67.05 -65.45 -61.98 -40.89 -52.96 -48.19 -44.76 -30.85 -45.57 -48.22 -58.18 -48.30 -66.69 -70.36 -64.95 -45.80 -79.69 -174.72 -192.95 -211.32 -186.54 -85.35 -51.76 -28.50 -39.07 -33.21 -44.76 -46.26 -134.30 -137.59 -191.63 -189.24 -82.47 -78.11 -16.79 -11.16 -17.21 -21.69 -25.88 -44.12 -41.49 -41.70 -39.88 -23.76 -19.37 -9.39 -4.30 - - - - - - - -

ROA %

-50.97 -49.61 -46.91 -30.88 -39.50 -35.45 -32.44 -21.93 -33.50 -29.79 -44.11 -37.09 -50.77 -52.89 -48.84 -34.07 -57.43 -121.93 -133.74 -145.66 -130.31 -62.87 -39.42 -25.04 -32.18 -26.33 -35.39 -35.59 -99.70 -101.91 -141.33 -139.23 -60.71 -57.68 -12.65 -8.58 -13.06 -16.27 -19.33 -32.86 -31.26 -32.22 -31.28 -19.61 -15.99 -7.75 -3.55 - - - - - - - -

ROCE %

-72.64 -70.65 -66.67 -43.81 -56.05 -50.23 -45.79 -28.07 -42.21 -44.12 -53.40 -46.37 -61.29 -62.07 -56.47 -40.70 -58.70 -168.90 -184.39 -197.89 -188.34 -79.40 -62.03 -44.84 -69.41 -60.29 -59.96 -60.79 -154.59 -156.87 -242.37 -242.18 -117.51 -118.78 -25.24 -18.68 -28.74 -25.90 -33.97 -37.45 -29.36 -27.75 -22.24 -20.53 -16.42 -10.25 -5.06 - - - - - - - -

Current Ratio

4.2 4.3 4.2 3.8 4.0 4.2 4.0 3.3 3.5 - 3.3 5.8 4.7 3.9 4.6 3.9 3.9 3.9 3.9 3.2 3.2 3.2 3.2 8.2 8.2 8.2 8.2 4.3 4.3 4.3 4.3 3.8 3.8 3.8 3.8 4.3 4.3 4.3 4.3 3.9 3.9 3.9 3.9 5.7 5.7 5.7 5.7 - - - - - - - -

DSO

115.0 103.2 116.6 - 46.9 51.8 27.4 - 14.1 4.2 8.0 - 40.5 50.2 55.6 - 78.6 79.1 77.0 67.9 35.9 168.2 177.1 53.5 53.5 74.9 35.6 14.5 5.3 35.3 131.1 -127.8 32.2 80.6 96.9 7.2 22.6 26.7 28.4 39.9 39.8 95.9 20.8 14.2 3.6 3.8 25.5 - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

115.0 103.2 116.6 - 46.9 51.8 27.4 - 14.1 4.2 8.0 - 40.5 50.2 55.6 - 78.6 79.1 77.0 67.9 35.9 168.2 177.1 53.5 53.5 74.9 35.6 14.5 5.3 35.3 131.1 -127.8 32.2 80.6 96.9 7.2 22.6 26.7 28.4 39.9 39.8 95.9 20.8 14.2 3.6 3.8 25.5 - - - - - - - -

Finanzkreislauf

115.0 103.2 116.6 - 46.9 51.8 27.4 - 14.1 4.2 8.0 - 40.5 50.2 55.6 - 78.6 79.1 77.0 67.9 35.9 168.2 177.1 53.5 53.5 74.9 35.6 14.5 5.3 35.3 131.1 -127.8 32.2 80.6 96.9 7.2 22.6 26.7 28.4 39.9 39.8 95.9 20.8 14.2 3.6 3.8 25.5 - - - - - - - -

Alle Zahlen in USD-Währung